Intravitreal Ranibizumab in Diabetic Macular Edema: Long-Term Outcomes.

In conclusion, randomized clinical trials showed that RBZ was superior to laser in DME treatment, providing excellent long-term visual outcomes. Frequent injections were necessary in most of the patients to properly control DME and maximize the visual benefits. PMID: 28427066 [PubMed - in process]
Source: Developments in Ophthalmology - Category: Opthalmology Tags: Dev Ophthalmol Source Type: research